Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.14
-0.07 (-1.34%)
At close: Mar 16, 2026, 4:00 PM EDT
5.21
+0.07 (1.36%)
Pre-market: Mar 17, 2026, 8:08 AM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $167.49 million as of March 17, 2026. Its market cap has increased by 40.03% in one year.
Market Cap
167.49M
Enterprise Value
54.44M
1-Year Change
40.03%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $167.49M, a decrease of -52.79%. That is a compound annual growth rate of -24.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 167.49M | -13.01% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 181.68M |
| Evaxion | 177.65M |
| Tonix Pharmaceuticals Holding | 177.49M |
| Milestone Pharmaceuticals | 172.69M |
| Corbus Pharmaceuticals Holdings | 166.90M |
| Heron Therapeutics | 166.23M |
| ProMIS Neurosciences | 162.76M |
| Kalaris Therapeutics | 162.15M |